Can Adipokine FAM19A5 Be a Biomarker of Metabolic Disorders?
DOI: https://doi.org/10.2147/dmso.s460226
2024-04-10
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Agnieszka Weso&lstrokek-Leszczy&nacuteska, 1, 2 Katarzyna Pastusiak, 1 Pawe&lstrok Bogda&nacuteski, 1, &ast Monika Szuli&nacuteska 1, &ast 1 Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Pozna&nacute, Poland; 2 Doctoral School, Poznan University Of Medical Sciences, Pozna&nacute, Poland &astThese authors contributed equally to this work Correspondence: Agnieszka Weso&lstrokek-Leszczy&nacuteska, Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, 82/84 Szamarzewskiego Street, Pozna&nacute, 60-569, Poland, Tel +48 721 947 738, Email ; Aim: One of the most critical functions of adipose tissue is the production of adipokines, ie, numerous active substances that regulate metabolism. One is the newly discovered FAM19A5, whose older name is TAFA-5. Purpose: The study aimed to review the literature on the FAM19A5 protein. Methods: The review was conducted in December 2023 using the PubMed (Medline) search engine. Sixty-four papers were included in the review. Results: This protein exhibits the characteristics of an adipokine with positive features for maintaining homeostasis. The results showed that FAM19A5 was highly expressed in adipose tissue, with mild to moderate expression in the brain and ovary. FAM19A5 may also inhibit vascular smooth muscle cell proliferation and migration through the perivascular adipose tissue paracrine pathway. Serum levels of FAM19A5 were decreased in obese children compared with healthy controls. There are negative correlations between FAM19A5, body mass index, and fasting insulin. Serum FAM19A5 level is correlated with type 2 diabetes, waist circumference, waist-to-hip ratio, glutamic pyruvic transferase, fasting plasma glucose, HbA1c, and mean shoulder pulse wave velocity. FAM19A5 expression was reduced in mice with obesity. However, the data available needs to be clarified or contradictory. Conclusion: Considering today's knowledge about FAM19A5, we cannot consider this protein as a biomarker of the metabolic syndrome. According to current knowledge, FAM19A5 cannot be considered a marker of metabolic disorders because the results of studies conducted in this area are unclear. Keywords: fat tissue, metabolic syndrome, adipokines, adipocytes, obesity Adipose tissue, in addition to its energy storage function, is a vital endocrine organ. It also protects against heat loss and mechanical injuries. One of the most critical functions of adipose tissue is the production of adipokines, ie, numerous active substances that regulate metabolism. Both excess and deficiency of adipose tissue negatively affect health. Overall mortality, cardiovascular diseases, metabolic diseases, and obesity are related to body fat content. Visceral fat tissue is particularly metabolically active. 1 The essential component of adipose tissue is adipocytes, scattered within the skeleton formed by collagen fibers. There is a subpopulation in adipose tissue stem cells called stromal vascular fraction cells (SVF) and preadipocytes, fibroblasts, leukocytes, macrophages, and endothelial cells. All these elements influence the metabolic function of adipose tissue, regardless of its morphological type. White adipose tissue (WAT) is the largest body store of energy, accumulated in triglycerides (TG), and is the largest endocrine gland—brown adipose tissue (BAT) functions to generate thermal energy, mainly in children. Pink adipose tissue is involved in milk production in women during pregnancy and lactation. Depending on the location of fat tissue in the body, it is divided into subcutaneous and visceral. Subcutaneous adipocytes are large and less metabolically active, while visceral adipocytes are small and more active. Visceral tissue is more metabolically active and secretes more hormone-like substances. Its increased content in obesity significantly increases the risk of cardiovascular diseases. 2,3 The summary of fat tissue's function is presented in Figure 1. Figure 1 Function of fat tissue in the human body. 8 Malnutrition and, consequently, too low body fat content may result in improper functioning of organs and, in children, growth retardation. 5 Obesity is a significant problem for the public health worldwide, because it has become an epidemic. According to the World Health Organization (WHO), more than 1 billion people worldwide have obesity — 650 million adults, 340 million adolescents, and 39 million children. 6,7 Assessing the concentration of bo -Abstract Truncated-
endocrinology & metabolism